The increase in abdominal aortic aneurysms (AAA) is viewed from the perspective of epidemiology, and initiatives to prevent death from rupture are discussed. Animal models and their relevance to pathophysiology and prevention are also presented, and the interventional pharmacology is also considered from the perspective of enzymology.